Dupilumab in combination with other biologic agents is safe and effective for treating various chronic inflammatory conditions.

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

Lung function trajectories for FEV1 and FVC increase rapidly in children until the mid-teens, then peak at age 20 in females and 23 years in males.

Frailty was a significant predictor of severe outcomes and hospitalization characteristics in older adults hospitalized with RSV infection.

Dupilumab in patients with diffuse type 2 CRSwNP had beneficial changes in nasal passage microbiota but did not alter gastrointestinal microbiota.

Moderna's Spikevax vaccine has been fully approved for children with high-risk conditions, the first vaccine to do so.

The CDC confirmed a nationwide uptick in COVID-19 cases, with increases seen in 25 states, suggesting a summer spike.

RFK Jr cancelled a meeting of the US Preventive Services Task Force, potentially interfering with their ability to make recommendations.

US funding cuts to global HIV prevention programs are estimated to cause 4 million deaths and 6 million cases of HIV.

Influenza significantly impacted adults aged 50 to 64 years and younger adults with chronic conditions, but risk can be reduced with RIV.

Use of a pMDI with a holding chamber is noninferior to nebulization for delivering salbutamol in children with asthma exacerbations.

PRISm may be a precursor to COPD regardless of an individual’s smoking status, although smokers have faster lung function decline.